Saturday |
2:00 pm - 5:00 pm | Arrival and Check-in |
3:30 pm - 3:45 pm | Introductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair |
3:45 pm - 5:45 pm | Understanding Drug-Likeness and Medicinal Chemistry Strategies |
| Discussion Leader: Amy Dounay (Colorado College, USA) |
3:45 pm - 3:55 pm | Introduction by Discussion Leader |
3:55 pm - 4:25 pm | Thomas Simpson (Boehringer Ingelheim Pharmaceuticals, USA) "What Makes a Good Lead?" |
4:25 pm - 4:40 pm | Discussion |
4:40 pm - 5:10 pm | Mark Tichenor (Janssen Research & Development LLC, USA) "Strategies for Lead Optimization" |
5:10 pm - 5:25 pm | Discussion |
5:25 pm - 5:45 pm | General Discussion |
6:00 pm | Dinner |
7:30 pm - 9:30 pm | Absorption, Distribution, Metabolism, Excretion, and Toxicity |
| Discussion Leader: Srinivasa Karra (EMD Serono Research & Development Institute, USA) |
7:30 pm - 7:40 pm | Introduction by Discussion Leader |
7:40 pm - 8:10 pm | Kimberly Cameron (Pfizer, USA) "Medicinal Chemistry Lead Optimization: The Use of In Vitro Assays to Solve ADME and Safety Issues" |
8:10 pm - 8:25 pm | Discussion |
8:25 pm - 8:55 pm | Christopher Smith (COI Pharmaceuticals, USA) "Addressing Issues Identified by Second-Tier ADMET Assays" |
8:55 pm - 9:10 pm | Discussion |
9:10 pm - 9:30 pm | General Discussion |
9:45 pm - 11:00 pm | Poster Session |
Sunday |
7:30 am - 8:30 am | Breakfast |
9:00 am - 11:00 am | Translation into Animal Models |
| Discussion Leader: David Kummer (Janssen, Johnson & Johnson, USA) |
9:00 am - 9:10 am | Introduction by Discussion Leader |
9:10 am - 9:40 am | Margaret Chu-Moyer (Amgen, USA) "A Medicinal Chemist's Primer on Pharmacokinetics" |
9:40 am - 9:55 am | Discussion |
9:55 am - 10:25 am | David Price (Pfizer Inc., USA) "In Vivo Models and PKPD, First Principles" |
10:25 am - 10:40 am | Discussion |
10:40 am - 11:00 am | General Discussion |
11:00 am - 12:30 pm | Poster Session |
| Coffee will be served in the poster area from 11:00 am - 11:30 am |
12:30 pm | Lunch |
1:30 pm - 2:30 pm | Case Studies in Medicinal Chemistry |
| Discussion Leader: Christoph Boss (Actelion Pharmaceuticals Ltd., Switzerland) |
1:30 pm - 1:50 pm | Kim Huard (Pfizer, USA) "Sodium-Coupled Citrate Transporter (NaCT or SLC13A5) Inhibitors for the Treatment of Metabolic Diseases" |
1:50 pm - 1:55 pm | Discussion |
1:55 pm - 2:15 pm | Patrick Stoy (GlaxoSmithKline, USA) "TRPV4 Antagonists: A Case Study in Managing Lipophilicity" |
2:15 pm - 2:20 pm | Discussion |
2:20 pm - 2:30 pm | Closing Remarks |
2:30 pm - 3:00 pm | Evaluation Period |
| Fill in GRS Evaluation Forms |
3:00 pm | Seminar Concludes |